Heparin characterization: Challenges and solutions

Annual Review of Analytical Chemistry

Volumn 4, Issue , 2011, Pages 439-465

  Jones, Christopher J ^a   Beni, Szabolcs ^a,b   Limtiaco, John F K ^a   Langeslay, Derek J ^a   Larive, Cynthia K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

CE; cITP; HPLC; mass spectrometry; microcoil; NMR; SEC

Indexed keywords

ASSEMBLY PROCESS; BOTTOM UP APPROACH; CITP; COMPONENT OLIGOSACCHARIDES; ENZYMATIC REACTION; EPIMERS; GLYCOSAMINOGLYCANS; HEPARAN SULFATES; HEXASACCHARIDES; HPLC; MICROCOILS; MICROHETEROGENEITY; MOLECULAR LEVELS; SEC; SENSITIVE MASS; SIZE POLYDISPERSITY; URONIC ACIDS;

BIOCHEMISTRY; CARBOXYLIC ACIDS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; NUCLEIC ACIDS; POLYDISPERSITY; RESONANCE;

POLYSACCHARIDES;

HEPARIN;

CARBOHYDRATE ANALYSIS; CHEMISTRY; MASS SPECTROMETRY; MOLECULAR GENETICS; REVIEW;

CARBOHYDRATE SEQUENCE; HEPARIN; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA;

EID: 79959526692     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev-anchem-061010-113911     Document Type: Review

References (128)

1. Gandhi NS, Mancera RL. 2008. The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72:455-82
2. Rabenstein DL. 2002. Heparin and heparan sulfate: structure and function. Nat. Prod. Rep. 19:312-31 (Pubitemid 34656777)
3. Linhardt RJ. 2003. 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. J. Med. Chem. 46:2551-64 (Pubitemid 36702523)
4. Victor XV, Nguyen TKN, Ethirajan M, Tran VM, Nguyen KV, Kuberan B. 2009. Investigating the elusive mechanism of glycosaminoglycan biosynthesis. J. Biol. Chem. 284:25842-53
5. Tumova S, Woods A, Couchman JR. 2000. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell Biol. 32:269-88 (Pubitemid 30069970)
6. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U. 2002. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2:521-28 (Pubitemid 37328933)
7. Mitsiadis TA, Salmivirta M, Muramatsu T, Muramatsu H, Rauvala H, et al. 1995. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelialmesenchymal interactions during fetal development and organogenesis. Development 121:37-51
8. Makarenkova HP, Hoffman MP, Beenken A, Eliseenkova AV, Meech R, et al. 2009. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal. 2:ra55
9. Iozzo RV, San Antonio JD. 2001. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Microbiol. 108:349-55 (Pubitemid 32730778)
10. Muramatsu T, Muramatsu H. 2008. Glycosaminoglycan-binding cytokines as tumor markers. Proteomics 8:3350-59
11. Kresse H, Schönherr E. 2001. Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 189:266-74 (Pubitemid 33063294)
12. Lyon M, Gallagher JT. 1998. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol. 17:485-93 (Pubitemid 28566883)
13. Li J-P, Vlodavsk I. 2009. Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb. Haemost. 102:823-28
14. Holt CE, Dickson BJ. 2005. Sugar codes for axons? Neuron 46:169-72 (Pubitemid 40545773)
15. Dityatev A, Schachner M. 2003. Extracellular matrix molecules and synaptic plasticity. Nat. Rev. Neurosci. 4:456-68 (Pubitemid 37280167)
16. De Mattos DA, Stelling MP, Tovar AMF, Mourao PAS. 2008. Heparan sulfates from arteries and veins differ in their antithrombin-mediated anticoagulant activity. J. Thromb. Haemost. 6:1987-90
17. Van Putten JPM, Paul SM. 1995. Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J. 14:2144-54
18. Rostand KS, Esko JD. 1997. Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65:1-8 (Pubitemid 27008896)
19. Bartlett AH, Park PW. 2010. Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications. Expert Rev. Mol. Med. 12:e5
20. Barrowcliffe TW. 1995. Low molecular weight heparin(s). Br. J. Haematol. 90:1-7
21. Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, et al. 2008. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat. Biotechnol. 26:669-75 (Pubitemid 351824692)
22. Beni S, Limtiaco JFK, Larive CK. 2011. Analysis and characterization of heparin impurities. Anal. Bioanal. Chem. 399:517-39
23. Guerrini M, Zhang ZQ, Shriver Z, Naggi A, Masuko S, et al. 2009. Orthogonal analytical approaches to detect potential contaminants in heparin. Proc. Natl. Acad. Sci. USA 106:16956-61
24. Tran V, Nguyen T, Raman K, Kuberan B. 2011. Applications of isotopes in advancing structural and functional heparanomics. Anal. Bioanal. Chem. 399:559-70
25. Yang B, Solakyildrim K, Chang Y, Linhardt RJ. 2011. Hyphenated techniques for the analysis of heparin and heparan sulfate. Anal. Bioanal. Chem. 399:541-57
26. Langesley DJ, Jones CJ, Beni S, Larive CK. 2011. Glycoaminoglycans: oligosaccharide analysis by liquid chromatography/specific labeling. Methods Mol. Biol. In press
27. Jandik KA, Gu KA, Linhardt RJ. 1994. Action pattern of polysaccharide lyases on glycosaminoglycans. Glycobiology 4:289-96 (Pubitemid 24217245)
28. Desai UR, Wang HM, Linhardt RJ. 1993. Specificity studies on the heparin lyases from flavobacterium heparinum. Biochemistry 32:8140-45 (Pubitemid 23265801)
29. Mardiguian J. 1984. Heparin esters and processes for their preparation. U. S. Patent No. 4,440,926
30. Shively JE, Conrad HE. 1976. Formation of anhydrosugars in chemical depolymerization of heparin. Biochemistry 15:3932-42
31. Rota C, Liverani L, Spelta F, Mascellani G, Tomasi A, et al. 2005. Free radical generation during chemical depolymerization of heparin. Anal. Biochem. 344:193-203 (Pubitemid 41208129)
32. Vismara E, Pierini M, Mascellani G, Liverani L, Lima M, et al. 2010. Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes. Thromb. Haemost. 103:613-22
33. Roger O, Colliec-Jouault S, Ratiskol J, Sinquin C, Guezennec J, et al. 2002. Polysaccharide labelling: impact on structural and biological properties. Carbohydr. Polym. 50:273-78 (Pubitemid 35432532)
34. Kariya Y, Herrmann J, Suzuki K, Isomura T, Ishihara M. 1998. Disaccharide analysis of heparin and heparan sulfate using deaminative cleavage with nitrous acid and subsequent labeling with paranitrophenyl hydrazine. J. Biochem. 123:240-46 (Pubitemid 28120756)
35. Bienkowski MJ, Conrad HE. 1985. Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid. J. Biol. Chem. 260:356-65 (Pubitemid 15164059)
36. Perkin Elmer. 2010. Guide to the Safe Handling of Radioactive Materials in Research. Waltham, Mass. : Perkin Elmer. http://las. perkinelmer. com/content/manuals/gde-safehandlingradioactivematerials. pdf
37. Behr JR, Matsumoto Y, White FM, Sasisekharan R. 2005. Quantification of isomers from a mixture of twelve heparin and heparan sulfate disaccharides using tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19:2553-62 (Pubitemid 41338597)
38. Camara JE, Satterfield MB, Nelson BC. 2007. Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry. J. Pharm. Biomed. Anal. 43:1706-14 (Pubitemid 46453090)
39. Saad OM, Ebel H, Uchimura K, Rosen SD, Bertozzi CR, Leary JA. 2005. Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase. Glycobiology 15:812-26
40. Saad OM, Leary JA. 2003. Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. Anal. Chem. 75:2985-95 (Pubitemid 36830424)
41. Chuang W-L, McAllister H, Rabenstein DL. 2001. Chromatographicmethods for product-profile analysis and isolation of oligosaccharides produced by heparinase-catalyzed depolymerization of heparin. J. Chromatogr. A 932:65-74 (Pubitemid 32938187)
42. Ziegler A, Zaia J. 2006. Size-exclusion chromatography of heparin oligosaccharides at high and low pressure. J. Chromatogr. B 837:76-86 (Pubitemid 43783322)
43. Eldridge SL, Korir AK, Gutierrez SM, Campos F, Limtiaco JFK, Larive CK. 2008. Heterogeneity of depolymerized heparin SEC fractions: to pool or not to pool? Carbohydr. Res. 343:2963-70
44. Henriksen J, Ringborg LH, Roepstorrf P. 2004. On-line size-exclusion chromatography/mass spectrometry of low molecular mass heparin. J. Mass Spectrom. 39:1305-12 (Pubitemid 39545980)
45. Seyrek E, Dubin PL, Henriksen J. 2007. Nonspecific electrostatic binding characteristics of the heparinantithrombin interaction. Biopolymers 86:249-59 (Pubitemid 46910396)
46. Zaia J, Costello CE. 2001. Compositional analysis of glycosaminoglycans by electrospray mass spectrometry. Anal. Chem. 73:233-39 (Pubitemid 32061834)
47. Campa C, Coslovi A, Flamigni A, Rossi M. 2006. Overview on advances in capillary electrophoresis-mass spectrometry of carbohydrates: a tabulated review. Electrophoresis 27:2027-50 (Pubitemid 43942106)
48. El Rassi Z, Mechref Y. 1996. Recent advances in capillary electrophoresis of carbohydrates. Electrophoresis 17:275-301 (Pubitemid 26089116)
49. Gunay NS, Linhardt RJ. 2003. Capillary electrophoretic separation of heparin oligosaccharides under conditions amenable to mass spectrometric detection. J. Chromatogr. A 1014:225-33 (Pubitemid 37311174)
50. Ruiz-Calero V, Puignou L, Galceran MT. 1998. Use of reversed polarity and a pressure gradient in the analysis of disaccharide composition of heparin by capillary electrophoresis. J. Chromatogr. A 828:497-508 (Pubitemid 29046451)
51. Patel RP, Narkowicz C, Hutchinson JP, Hilder EF, Jacobson GA. 2008. A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins. J. Pharm. Biomed. Anal. 46:30-35 (Pubitemid 350216339)
52. Laremore TN, Ly M, Solakyildirim K, Zagorevski DV, Linhardt RJ. 2010. High-resolution preparative separation of glycosaminoglycan oligosaccharides by polyacrylamide gel electrophoresis. Anal. Biochem. 401:236-41
53. Pervin A, Gallo C, Jandik KA, Han XJ, Linhardt RJ. 1995. Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology 5:83-95
54. Rice KG, Rottink MK, Linhardt RJ. 1987. Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis. Biochem. J. 244:515-22
55. Zilberstein G, Shlar I, Korol L, Baskin E, Fasoli E, et al. 2009. Focusing of low-molecular-mass heparins in polycationic polyacrylamide matrices. Anal. Chem. 81:6966-71
56. Imanari T, Toida T, Koshiishi I, Toyoda H. 1996. High-performance liquid chromatographic analysis of glycosaminoglycan-derived oligosaccharides. J. Chromatogr. A 720:275-93 (Pubitemid 26037622)
57. Rice KG, Kim YS, Merchant ZM, Linhardt RJ. 1985. High-performance liquid chromatographic separation of heparin-derived oligosaccharides. Anal. Biochem. 150:325-31 (Pubitemid 16201194)
58. Limtiaco JFK, Jones CJ, Larive CK. 2009. Characterization of heparin impurities with HPLC-NMR using weak anion exchange chromatography. Anal. Chem. 81:10116-23
59. Hitchcock AM, Yates EA, Costello CE, Zaia J. 2008. Comparative glycomics of connective tissue glycosaminoglycans. Proteomics 8:1384-97 (Pubitemid 351518550)
60. Staples GO, Bowman MJ, Costello CE, Hitchcock AM, Lau JM, et al. 2009. A chip-based amide-HILIC LC/MS platform for glycosaminoglycan glycomics profiling. Proteomics 9:686-95
61. Karlsson NG, Schulz BL, Packer NH, Whitelock JM. 2005. Use of graphitised carbon negative ion LC-MS to analyse enzymatically digested glycosaminoglycans. J. Chromatogr. B 824:139-47 (Pubitemid 41215591)
62. Cecchi T. 2008. Ion pairing chromatography. Crit. Rev. Anal. Chem. 38:161-213
63. Lochmüller CH, Cecchi T, eds. 2009. Ion-Pair Chromatography and Related Techniques. Boca Raton: Taylor & Francis. 215 pp.
64. Cecchi T, Pucciarelli F, Passamonti P. 2001. Extended thermodynamic approach to ion interaction chromatography. Anal. Chem. 73:2632-39 (Pubitemid 32880668)
65. Karamanos NK, Vanky P, Tzanakakis GN, Tsegenidis T, Hjerpe A. 1997. Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. J. Chromatogr. A 765:169-79 (Pubitemid 27152227)
66. Thanawiroon C, Linhardt RJ. 2003. Separation of a complex mixture of heparin-derived oligosaccharides using reversed-phase high-performance liquid chromatography. J. Chromatogr. A 1014:215-23 (Pubitemid 37311173)
67. Thanawiroon C, Rice KG, Toida T, Linhardt RJ. 2004. Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides. J. Biol. Chem. 279:2608-15 (Pubitemid 38114247)
68. Toyoda H, Yamamoto H, Ogino N, Toida T, Imanari T. 1999. Rapid and sensitive analysis of disaccharide composition in heparin and heparan sulfate by reversed-phase ion-pair chromatography on a 2 μm porous silica gel column. J. Chromatogr. A 830:197-201 (Pubitemid 29034693)
69. Sinnis P, Coppi A, Toida T, Toyoda H, Kinoshita-Toyoda A, et al. 2007. Mosquito heparan sulfate and its potential role in malaria infection and transmission. J. Biol. Chem. 282:25376-84 (Pubitemid 47372810)
70. Toyoda H, Kinoshita-Toyoda A, Selleck SB. 2000. Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo. J. Biol. Chem. 275:2269-75 (Pubitemid 30081981)
71. Doneanu CE, Chen W, Gebler JC. 2009. Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry. Anal. Chem. 81:3485-99
72. Henriksen J, Roepstorff P, Ringborg LH. 2006. Ion-pairing reversed-phased chromatography/mass spectrometry of heparin. Carbohydr. Res. 341:382-87 (Pubitemid 43098777)
73. Kuberan B, Lech M, Zhang L, Wu ZL, Beeler DL, Rosenberg RD. 2002. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography- microelectrospray ionization time-of-flight mass spectrometry. J. Am. Chem. Soc. 124:8707-18 (Pubitemid 34791042)
74. Zhang Z, Xie J, Liu H, Liu J, Linhardt RJ. 2009. Quantification of heparan sulfate disaccharides using ionpairing reversed-phasemicroflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry. Anal. Chem. 81:4349-55
75. Korir AK, Limtiaco JFK, Gutierrez SM, Larive CK. 2008. Ultraperformance ion-pair liquid chromatography coupled to electrospray time-of-flight mass spectrometry for compositional profiling and quantification of heparin and heparan sulfate. Anal. Chem. 80:1297-306 (Pubitemid 351272368)
76. Jones CJ, Membreno N, Larive CK. 2010. Insights into the mechanism of separation of heparin and heparan sulfate disaccharides by reversed-phase ion-pair chromatography. J. Chromatogr. A 1217:479-88
77. Chi LL, Amster J, Linhardt RJ. 2005. Mass spectrometry for the analysis of highly charged sulfated carbohydrates. Curr. Anal. Chem. 1:223-40
78. Zaia J, Costello CE. 2003. Tandem mass spectrometry of sulfated heparin-like glycosaminoglycan oligosaccharides. Anal. Chem. 75:2445-55 (Pubitemid 36582831)
79. Zaia J, Miller MJC, Seymour JL, Costello CE. 2007. The role of mobile protons in negative ion CID of oligosaccharides. J. Am. Soc. Mass Spectrom. 18:952-60 (Pubitemid 46617286)
80. Juhasz P, Biemann K. 1995. Utility of noncovalent complexes in the matrix-assisted laser-desorption ionization mass spectrometry of heparin-derived oligosaccharides. Carbohydr. Res. 270:131-47
81. Ueki M, Yamaguchi M. 2005. Analysis of acidic carbohydrates as their quaternary ammonium or phosphonium salts by matrix-assisted laser desorption/ionization mass spectrometry. Carbohydr. Res. 340:1722-31 (Pubitemid 40828480)
82. Laremore TN, Linhardt RJ. 2007. Improved matrix-assisted laser desorption/ionization mass spectrometric detection of glycosaminoglycan disaccharides as cesium salts. Rapid Commun. Mass Spectrom. 21:1315-20 (Pubitemid 46506587)
83. Tissot B, Gasiunas N, Powell AK, Ahmed Y, Zhi ZL, et al. 2007. Towards GAG glycomics: analysis of highly sulfated heparins by MALDI-TOF mass spectrometry. Glycobiology 17:972-82 (Pubitemid 47423887)
84. Bultel L, Landoni M, Grand E, Couto AS, Kovensky J. 2010. UV-MALDI-TOFmass spectrometry analysis of heparin oligosaccharides obtained by nitrous acid controlled degradation and high performance anion exchange chromatography. J. Am. Soc. Mass Spectrom. 21:178-90
85. Meissen JK, Sweeney MD, Girardi M, Lawrence R, Esko JD, Leary JA. 2009. Differentiation of 3-Osulfated heparin disaccharide isomers: identification of structural aspects of the heparin CCL2 binding motif. J. Am. Soc. Mass Spectrom. 20:652-57
86. Minamisawa T, Suzuki K, Hirabayashi J. 2006. Systematic identification of N-acetylheparosan oligosaccharides by tandem mass spectrometric fragmentation. Rapid Commun. Mass Spectrom. 20:267-74 (Pubitemid 43121630)
87. Wolff JJ, Chi LL, Linhardt RJ, Amster IJ. 2007. Distinguishing glucuronic from iduronic acid in glycosaminoglycan tetrasaccharides by using electron detachment dissociation. Anal. Chem. 79:2015-22 (Pubitemid 46355233)
88. Chuang WL, Christ MD, Peng J, Rabenstein DL. 2000. An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides. Biochemistry 39:3542-55 (Pubitemid 30183835)
89. Chuang WL, Christ MD, Rabenstein DL. 2001. Determination of the primary structures of heparin- and heparan sulfate-derived oligosaccharides using band-selective homonuclear-decoupled two-dimensional H-1 NMR experiments. Anal. Chem. 73:2310-16 (Pubitemid 32880699)
90. McEwen I. 2010. Broadening of H-1 NMR signals in the spectra of heparin and OSCS by paramagnetic transition metal ions. The use of EDTA to sharpen the signals. J. Pharm. Biomed. Anal. 51:733-35
91. Mourier PAJ, Viskov C. 2004. Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases. Anal. Biochem. 332:299- 313 (Pubitemid 39485739)
92. Mascellani G, Guerrini M, Torri G, Liverani L, Spelta F, Bianchini P. 2007. Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1, 6-anhydro-β-Dglucosamine or N-sulfated 1, 6-anhydro-β-D-mannosamine residues. Carbohydr. Res. 342:835-42
93. Yamada S, Yoshida K, Sugiura M, Sugahara K. 1992. One- and two-dimensional 1H-NMR characterization of two series of sulfated disaccharides prepared from chondroitin sulfate and heparan-sulfate heparin by bacterial eliminase digestion. J. Biochem. 112:440-47
94. Yates EA, Santini F, Guerrini M, Naggi A, Torri G, Casu B. 1996. 1Hand13CNMRspectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydr. Res. 294:15-27
95. Bendiak B, Fang TT, Jones DNM. 2002. An effective strategy for structural elucidation of oligosaccharides through NMRspectroscopy combined with peracetylation using doubly 13C-labeled acetyl groups. Can. J. Chem. 80:1032-50 (Pubitemid 35373399)
96. Jones DNM, Bendiak B. 1999. Novel multi-dimensional heteronuclear NMR techniques for the study of 13C-O-acetylated oligosaccharides: expanding the dimensions for carbohydrate structures. J. Biomol. NMR 15:157-68
97. Jayawickrama DA, Larive CK, McCord EF, Roe DC. 1998. Polymer additives mixture analysis using pulsed-field gradient NMR spectroscopy. Magn. Reson. Chem. 36:755-60
98. Johnson CS Jr. 1999. Diffusion ordered nuclear magnetic resonance spectroscopy: principles and applications. Prog. Nucl. Magn. Reson. Spectrosc. 34:203-56 (Pubitemid 129595218)
99. Morris KF, Johnson CS. 1992. Diffusion-ordered two-dimensional nuclear magnetic resonance spectroscopy. J. Am. Chem. Soc. 114:3139-41
100. Morris KF, Stilbs P, Johnson CS. 1994. Analysis ofmixtures based onmolecular size and hydrophobicity by means of diffusion-ordered 2D NMR. Anal. Chem. 66:211-15
101. Sitkowski J, Bednarek E, Bocian W, Kozerski L. 2008. Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractionated heparin diffusion ordered nuclear magnetic resonance spectroscopy method. J. Med. Chem. 51:7663-65
102. Bednarek E, Sitkowski J, Bocian W, Mulloy B, Kozerski L. 2010. An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method. J. Pharm. Biomed. Anal. 53:302-8
103. Limtiaco JFK, Beni S, Jones CJ, Langesley D, Larive CK. 2011. NMRmethods to monitor the enzymatic depolymerization of heparin. Anal. Bioanal. Chem. 399:593-603
104. Serber Z, Richter C, Moskau D, Bohlen J-M, Gerfin T, et al. 2000. New carbon-detected protein NMR experiments using cryoprobes. J. Am. Chem. Soc. 122:3554-55 (Pubitemid 30211144)
105. Spraul M, Freund AS, Nast RE, Withers RS, Maas WE, Corcoran O. 2003. Advancing NMR sensitivity for LC-NMR-MS using a cryoflow probe: application to the analysis of acetaminophen metabolites in urine. Anal. Chem. 75:1536-41 (Pubitemid 36397188)
106. Schroeder FC, Gronquist M. 2006. Extending the scope of NMR spectroscopy with microcoil probes. Angew. Chem. Int. Ed. 45:7122-31 (Pubitemid 44748293)
107. Korir AK, Larive CK. 2007. On-line NMR detection of microgram quantities of heparin-derived oligosaccharides and their structure elucidation by microcoil NMR. Anal. Bioanal. Chem. 388:1707-16 (Pubitemid 47173090)
108. Jayawickrama DA, Sweedler JV. 2003. Hyphenation of capillary separations with nuclear magnetic resonance spectroscopy. J. Chromatogr. A 1000:819-40 (Pubitemid 36638487)
109. Kautz RA, Lacey ME, Wolters AM, Foret F, Webb AG, et al. 2001. Sample concentration and separation for nanoliter-volume NMRspectroscopy using capillary isotachophoresis. J. Am. Chem. Soc. 123:3159-60 (Pubitemid 32879593)
110. Lacey ME, Subramanian R, Olson DL, Webb AG, Sweedler JV. 1999. High-resolution NMR spectroscopy of sample volumes from 1 n L to 10 μL. Chem. Rev. 99:3133-52 (Pubitemid 129582907)
111. Olson D, Lacey M, Webb A, Sweedler J. 1999. Nanoliter-volume 1H NMR detection using periodic stopped-flow capillary electrophoresis. Anal. Chem. 71:3070-76 (Pubitemid 29372720)
112. Wolters AM, Jayawickrama DA, Larive CK, Sweedler JV. 2002. Insights into the c ITP process using on-line NMR spectroscopy. Anal. Chem. 74:4191-97 (Pubitemid 34912921)
113. Korir AK, Almeida VK, Malkin DS, Larive CK. 2005. Separation and analysis of nanomole quantities of heparin oligosaccharides using on-line capillary isotachophoresis coupled with NMR detection. Anal. Chem. 77:5998-6003 (Pubitemid 41324302)
114. Korir AK, Almeida VK, Larive CK. 2006. Visualizing ion electromigration during isotachophoretic separations with capillary isotachophoresis-NMR. Anal. Chem. 78:7078-87 (Pubitemid 44607548)
115. Korir AK, Larive CK. 2009. Advances in the separation, sensitive detection, and characterization of heparin and heparan sulfate. Anal. Bioanal. Chem. 393:155-69 (Pubitemid 50295243)
116. Eldridge SL, Almeida VK, Korir AK, Larive CK. 2007. Separation and analysis of trace degradants in a pharmaceutical formulation using on-line capillary isotachophoresis-NMR. Anal. Chem. 79:8446-53 (Pubitemid 350171351)
117. Bowen S, Hilty C. 2008. Time-resolved dynamic nuclear polarization enhanced NMR spectroscopy. Angew. Chem. Int. Ed. 47:5235-37
118. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, et al. 2003. Increase in signal-tonoise ratio of >10, 000 times in liquid-state NMR. Proc. Natl. Acad. Sci. USA 100:10158-63 (Pubitemid 37071849)
119. Frydman L, Lupulescu A, Scherf T. 2003. Principles and features of single-scan two-dimensional NMR spectroscopy. J. Am. Chem. Soc. 125:9204-17 (Pubitemid 36903835)
120. Zeng H, Bowen S, Hilty C. 2009. Sequentially acquired two-dimensional NMR spectra from hyperpolarized sample. J. Magn. Reson. 199:159-65
121. Hricovíni M. 2006. B3LYP/6-3112+G study of structure and spin-spin coupling constant in methyl 2-O-sulfo-α-L-iduronate. Carbohydr. Res. 341:2575-80 (Pubitemid 44427780)
122. Pol-Fachin L, Verli H. 2008. Depiction of the forces participating in the 2-O-sulfo-α-L-iduronic acid conformational preference in heparin sequences in aqueous solutions. Carbohydr. Res. 343:1435-45
123. Mikhailov D, Linhardt RJ, Mayo KH. 1997. NMR solution conformation of heparin-derived hexasaccharide. Biochem. J. 328:51-61 (Pubitemid 27499439)
124. Mikhailov D, Mayo KH, Vlahov IR, Toida T, Pervin A, Linhardt RJ. 1996. NMRsolution conformation of heparin-derived tetrasaccharide. Biochem. J. 318:93-102
125. Lipsitz RS, Tjandra N. 2004. Residual dipolar couplings in NMR structure analysis. Annu. Rev. Biophys. Biomol. Struct. 33:387-413 (Pubitemid 38829965)
126. Tian F, Bolon PJ, Prestegard JH. 1999. Intensity-based measurement of homonuclear residual dipolar couplings from CT-COSY. J. Am. Chem. Soc. 121:7712-13 (Pubitemid 29413740)
127. Jin L, Hricovini M, Deakin JA, Lyon M, Uhrin D. 2009. Residual dipolar coupling investigation of a heparin tetrasaccharide confirms the limited effect of flexibility of the iduronic acid on the molecular shape of heparin. Glycobiology 19:1185-96
128. Yu F, Prestegard JH. 2006. Structural monitoring of oligosaccharides through 13Cenrichment and NMR observation of acetyl groups. Biophys. J. 91:1952-59 (Pubitemid 44352456)